Data as of Apr 15
| -0.34 / -0.68%|
The 18 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 55.50, with a high estimate of 65.00 and a low estimate of 41.00. The median estimate represents a +11.87% increase from the last price of 49.61.
The current consensus among 24 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.